TREATMENT WITH IMMUNOTHERAPY MAY HELP
Living with advanced non–small cell lung cancer is challenging. The more you know about your options, the more prepared you may be for talking with your doctor. The information below can help you prepare to talk about immunotherapy for advanced lung cancer and see if it may be right for you.
What is immunotherapy?
Immunotherapy is a type of treatment that works with your immune system to help detect and fight cancer cells. Instead of attacking cancer cells directly, immunotherapy helps your immune system do what it is designed to do: help your own body fight cancer. Be sure to tell your health care team about any side effects that you may be experiencing, because immunotherapy can also cause your immune system to attack healthy and normal cells. This can be serious or life-threatening and can lead to death. Learn more about KEYTRUDA for lung cancer.
Find out if you are a match for KEYTRUDA
Everyone's advanced non–small cell lung cancer is different. To help develop a treatment plan that's right for you, your doctor may order biomarker tests. These tests can measure your tumor for different biomarkers, including a biomarker called PD-L1. Biomarker tests are used to help predict your response to certain treatments, such as KEYTRUDA. Talk to your doctor to see if a PD-L1 biomarker test is right for you.
Ask your health care team if KEYTRUDA is right for you
Want more info about KEYTRUDA?
Sign up for regular updatesAlready prescribed KEYTRUDA?
Enroll in the KEY+YOUPatient Support ProgramNeed help talking to your doctor?
Download a doctor discussion guideFor more information or to sign up over the phone, call 85-KEYTRUDA .
KEYTRUDA is a prescription medicine used to treat a kind of lung cancer called non–small cell lung cancer (NSCLC). KEYTRUDA may be used alone as your first treatment when your lung cancer has spread (advanced NSCLC) and tests positive for “PD-L1” and your tumor does not have an abnormal “EGFR” or “ALK” gene.
KEYTRUDA may also be used alone for advanced NSCLC if you have tried chemotherapy that contains platinum and it did not work or is no longer working and your lung cancer tests positive for "PD-L1" and,if your tumor has an abnormal “EGFR” or “ALK” gene, you have also received an “EGFR” or “ALK” inhibitor medicine that did not work or is no longer working.
PD-L1 = programmed death ligand 1; EGFR = epidermal growth factor receptor;
ALK = anaplastic lymphoma kinase.
